Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier A Oldenburg

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Journal of Medical Genetics|May 29, 2012
Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomasFemme Harinck, Irma Kluijt, Nienke van der Stoep, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotypingRogier A Oldenburg, Karin Kroeze-Jansema, Hanne Meijers-Heijboer, et al.
Familial Cancer|May 9, 2024
Men with metastatic prostate cancer carrying a pathogenic germline variant in breast cancer genes: disclosure of genetic test results to relativesMichiel Vlaming, Margreet G E M Ausems, Gina Schijven, et al.
BMC Medical Genetics|October 11, 2014
Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutationsJean-Pierre Bayley, Rogier A Oldenburg, Jennifer Nuk, et al.
Cancer Research|December 18, 2003
The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case familiesRogier A Oldenburg, Karin Kroeze-Jansema, Jaennelle Kraan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 24, 2012
SDHA mutations in adult and pediatric wild-type gastrointestinal stromal tumorsLindsey Oudijk, José Gaal, Esther Korpershoek, et al.
Journal of Medical Genetics|November 8, 2011
CHEK2*1100delC homozygosity is associated with a high breast cancer risk in womenMuriel A Adank, Marianne A Jonker, Irma Kluijt, et al.
European Journal of Endocrinology|May 9, 2019
Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATEWouter T Zandee, Richard A Feelders, Daan A Smit Duijzentkunst, et al.
Genes, Chromosomes & Cancer|July 30, 2008
Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locusRogier A Oldenburg, Karin H G Kroeze-Jansema, Jeanine J Houwing-Duistermaat, et al.
Cancer Research|February 12, 2004
Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?Csilla I Szabo, Mieke Schutte, Annegien Broeks, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Journal of Medical Genetics|May 29, 2012
Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomasFemme Harinck, Irma Kluijt, Nienke van der Stoep, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotypingRogier A Oldenburg, Karin Kroeze-Jansema, Hanne Meijers-Heijboer, et al.
Familial Cancer|May 9, 2024
Men with metastatic prostate cancer carrying a pathogenic germline variant in breast cancer genes: disclosure of genetic test results to relativesMichiel Vlaming, Margreet G E M Ausems, Gina Schijven, et al.
BMC Medical Genetics|October 11, 2014
Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutationsJean-Pierre Bayley, Rogier A Oldenburg, Jennifer Nuk, et al.
Cancer Research|December 18, 2003
The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case familiesRogier A Oldenburg, Karin Kroeze-Jansema, Jaennelle Kraan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 24, 2012
SDHA mutations in adult and pediatric wild-type gastrointestinal stromal tumorsLindsey Oudijk, José Gaal, Esther Korpershoek, et al.
Journal of Medical Genetics|November 8, 2011
CHEK2*1100delC homozygosity is associated with a high breast cancer risk in womenMuriel A Adank, Marianne A Jonker, Irma Kluijt, et al.
European Journal of Endocrinology|May 9, 2019
Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATEWouter T Zandee, Richard A Feelders, Daan A Smit Duijzentkunst, et al.
Genes, Chromosomes & Cancer|July 30, 2008
Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locusRogier A Oldenburg, Karin H G Kroeze-Jansema, Jeanine J Houwing-Duistermaat, et al.
Cancer Research|February 12, 2004
Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?Csilla I Szabo, Mieke Schutte, Annegien Broeks, et al.
Pageof 5